Samuel E. DePrimo

6.7k citations
40 papers · 5.3k · 2 hit papers · h-index 28

Impact in

    • Cancer Genomics and Diagnostics
    • Cancer, Hypoxia, and Metabolism
  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Molecular Biology Techniques and Applications 4
    • Angiogenesis and VEGF in Cancer 3
    • Cancer-related Molecular Pathways 5
    • Colorectal Cancer Treatments and Studies 5
    • HER2/EGFR in Cancer Research 3

Samuel E. DePrimo

40 papers receiving 5.2k citations

Samuel E. DePrimo's Hit Papers

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma 2005 · 1.3k citations
1.3k0+7+14Years since publication4008001.2k

Peers

Samuel E. DePrimo
Comparison fields: 5 of 121
  • Cancer Research 1.3k
  • Oncology 2.2k
  • Pulmonary and Respiratory Medicine 2.5k
  • Gastroenterology 390
  • Hepatology 370
Replace Markus Borner with:
Markus Borner Switzerland
Robert Justice United States
Vincenzo Catalano Italy
Petri Bono Finland
Young Suk Park South Korea
Ferry A.L.M. Eskens Netherlands
Catherine Delbaldo France
Michele Orditura Italy
Joseph P. Eder United States
Allen Lee Cohn United States
Samuel E. DePrimo relative to Markus Borner Switzerland Markus Borner's profile →
Citations per field
00.5×1.5×2.4×
Markus Borner · 1×
Citations per year

Countries citing papers authored by Samuel E. DePrimo

Since Specialization
Citations

This map shows the geographic impact of Samuel E. DePrimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel E. DePrimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel E. DePrimo more than expected).

Fields of papers citing papers by Samuel E. DePrimo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel E. DePrimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel E. DePrimo. The network helps show where Samuel E. DePrimo may publish in the future.

Co-authors

The 25 scholars most cited alongside Samuel E. DePrimo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Samuel E. DePrimo Line = papers co-authored together Samuel E. DePrimo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
Hit paper breakdown →
20051304
2
Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer
Hit paper breakdown →
2005934
3 2008400
4 2008321
5 2009272
6 2007255
7 2009219
8 2010199
9 1999163
10 2002148
11 2007128
12 2006112
13 200299
14 200377
15 200567
16 201854
17 202050
18 199647
19 201347
20 200546

About Samuel E. DePrimo

Samuel E. DePrimo is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 40 papers that have together received 5.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Cancer-related Molecular Pathways (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Molecular Biology Techniques and Applications (4 papers), HER2/EGFR in Cancer Research (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (2.2k citations), Pulmonary and Respiratory Medicine (2.5k citations), Gastroenterology (390 citations) and Hepatology (370 citations). Samuel E. DePrimo has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Carlo L. Bello, Charles M. Baum, M. Dror Michaelson, Brian I. Rini, Robert J. Motzer, Sindy T. Kim, Daniel J. George, Gary R. Hudes, Robert A. Figlin and Sandrine Faivre. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Translational Medicine, Journal of Investigative Dermatology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact